DocMorris AG (ZRSEF)
DocMorris AG operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Frauenfeld, TH, CH. The stock last traded at $10.24, up 0.00% on the session, giving a market capitalisation of $500.4M. On trailing twelve-month figures it carries a trailing P/E of -3.64, a net margin of -12.0%. Its beta of 1.86 implies it has historically moved more than the broad market.
DocMorris AG, an enterprise headquartered in Frauenfeld, Switzerland, and founded in 1993, operates a dual business model encompassing e-commerce pharmacies and a wholesale distribution network for medical and pharmaceutical goods. Its market reach extends both within Switzerland and across international borders. The company's diverse offerings include consumer health, beauty, and personal care items, alongside services focused on medication management. Furthermore, DocMorris AG maintains physical pharmacy locations. It directly supplies its products to various clients, including medical professionals, online mail-order pharmacies, and individual consumers, utilizing several distinct brands such as Zur Rose, PromoFarma, TeleClinic, and DocMorris. The organization was initially known as Zur Rose AG before it changed its name to Zur Rose Group AG in May 2015.
DocMorris AG is most often compared with the following Healthcare names: